The promise of retinoids to fight against cancer

Nature Reviews Cancer

Volumn 1, Issue 3, 2001, Pages 181-193

  Altucci, Lucia ^a,b   Gronemeyer, Hinrich ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; RETINOIC ACID RECEPTOR; RETINOID; RETINOL; TRANSCRIPTION FACTOR AP 1; TUMOR PROTEIN;

APOPTOSIS; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DIMERIZATION; DRUG ANTAGONISM; DRUG EFFECT; FORECASTING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MORPHOGENESIS; NEOPLASM; PHYSIOLOGY; PROMYELOCYTIC LEUKEMIA; REVIEW; SIGNAL TRANSDUCTION; SKIN TUMOR; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION;

ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIFFERENTIATION; DIMERIZATION; FORECASTING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MODELS, BIOLOGICAL; MORPHOGENESIS; NEOPLASM PROTEINS; NEOPLASMS; ONCOGENE PROTEINS, FUSION; RECEPTOR CROSS-TALK; RECEPTORS, RETINOIC ACID; RETINOIDS; SKIN NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; VITAMIN A;

EID: 0035749803     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/35106036     Document Type: Article

References (21)

1. Niederreither, K., Subbarayan, V., Dolle, P. & Chambon, P. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nature Genet. 21, 444-448 (1999). Targeted gene disruption shows that production of retinoic acid by the retinaldehyde dehydrogenase-2 (Raldh2) enzyme is required for mouse embryo survival and early morphogenesis.
2. de Urquiza, A. M. et al. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290, 2140-2144 (2000). Identification of brain-derived docosahexaenoic acid as an RXR ligand.
3. Krezel, W. et al. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 279, 863-867 (1998).
4. Kastner, P. et al. Abnormal spermatogenesis in RXRβ mutant mice. Genes Dev. 10, 80-92 (1996).
5. Massaro, G.D. et al. Retinoic acid receptor-β: an endogenous inhibitor of the perinatal formation of pulmonary alveoli. Physiol. Genomics 4, 51-57 (2000).
6. Wan, Y. J. et al. Hepatocyte-specific mutation establishes retinoid X receptor-α as a heterodimeric integrator of multiple physiological processes in the liver. Mol. Cell Biol. 20, 4436-4444 (2000).
7. Imai, T., Jiang, M., Kastner, P., Chambon, P. & Metzger, D. Selective ablation of retinoid X receptor-α in hepatocytes impairs their lifespan and regenerative capacity. Proc. Natl Acad. Sci. USA 98, 4581-4586 (2001).
8. Dupe, V. et al. Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods. Dev. Biol. 208, 30-43 (1999).
9. Altucci, L. et al. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand trail. Nature Med. 7, 680-686 (2001). Retinoic-acid therapy of acute promyelocytic leukaemia Involves induction of cell differentiation linked to early-induced anti-apoptotic gene programming, which is followed by post-differentiation apoptosis caused by activation of the TRAIL signalling pathway.
10. Kastner, P. et al. Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 124, 313-326 (1997).
11. Chen, J. Y. et al. RAR-speciflc agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 14, 1187-1197 (1995).
12. Amhold, T., Tzimas, G., Wittfoht, W., Plonait, S. & Nau, H. Identification of 9-cis-retinoic acid, 9,13-di-cis-retinoic acid, and 14-hydroxy-4,14-retro-retinol in human plasma after liver consumption. Life Sci. 59, L169-L177 (1996).
13. Buck, J., Derguini, F., Levi, E., Nakanishi, K. & Hammerling, U. Intracellular signaling by 14-hydroxy-4,14-retra-retinol. Science 254, 1654-1656 (1991).
14. Bourguet, W. et al. Crystal structure of a heterodimeric complex of RAH and RXR ligand-binding domains. Mol. Cell 5, 289-298 (2000).
15. Jepsen, K. et al. Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 102, 753-763 (2000).
16. Bourguet, W., Germain, P. & Gronemeyer, H. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Phamacol. Sci. 21, 381-388 (2000).
17. Glass, C. K. & Rosenfeld, M. G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14, 121-141 (2000).
18. Rachez, C. & Freedman, L. P. Mediator complexes and transcription. Curr. Opin. Cell Biol. 13, 274-280 (2001).
19. Ito, M. & Reeder, R. G. The TRAP/SMCC/mediator complex and thyroid hormone receptor function. Trends Endocrinol. Metab. 12, 127-134 (2001).
20. Benoit, G. et al. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. EMBO J. 18, 7011-7018 (1999).
21. Benoit, G. R. et al. Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells. Mol. Endocrinol. 15, 1154-1169 (2001). Together with reference 20, this is the first demonstration of autonomous rexinoid signalling.